SCHEMBL6114224

SCHEMBL6114224

Cc1ccc(C(C)N[SiH3])cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CHRNA7 P36544 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ ACHE P22303 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CNR1 P21554 2/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ GRIA4 P48058 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ TAS1R3 Q7RTX0 1/20 0.34
▸ TAS1R1 Q7RTX1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25584028 0.80 SMN1; SMN2 (0.41) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL8278972 0.80 SMN1; SMN2 (0.41) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL26522401 0.78 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL28276361 0.77 SMN1; SMN2 (0.42) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL178538 0.77 ALDH1A1 (0.52) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL8284259 0.77 ALDH1A1 (0.52) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL6114559 0.77 CYP2D6 (0.50) SMN1; SMN2MEN1KMT2ANPSR1ALDH1A1
SCHEMBL19286213 0.77 SMN1; SMN2 (0.42) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL8285887 0.77 ALDH1A1 (0.52) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1
SCHEMBL2663534 0.75 LMNA (0.41) SMN1; SMN2CHRNA7MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912353-B2 Organoaminosilane precursors and methods for depositing films comprising same AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-12-16 — — US claimed
EP-2392691-B1 Organoaminosilane precursors and methods for depositing films comprising the same AIR PROD & CHEM (US) 2014-09-03 — — EP claimed
US-20120128897-A1 Organoaminosilane Precursors and Methods for Depositing Films Comprising Same AIR PRODUCTS AND CHEMICALS, INC. (US) 2012-05-24 — — US claimed
EP-2392691-A1 Organoaminosilane precursors and methods for depositing films comprising the same AIR PRODUCTS AND CHEMICALS, INC. (US) 2011-12-07 — — EP claimed
EP-2392691-B1 Organoaminosilane precursors and methods for depositing films comprising the same AIR PROD & CHEM (US) 2014-09-03 — — EP disclosed
EP-2392691-A1 Organoaminosilane precursors and methods for depositing films comprising the same AIR PRODUCTS AND CHEMICALS, INC. (US) 2011-12-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120128897-A1 Organoaminosilane Precursors and Methods for Depositing Films Comprising Same C1S, C9, C5 SMN1; SMN2 3298/4885CHRNA7 2032/4885MEN1 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback